Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Mühlemann, B.; Wilks, S. H.; Baracco, L.; Bekliz, M.; Carreno, J. M.; Corman, V. M.; Davis-Gardner, M. E.; Dejnirattisai, W.; Diamond, M.; Doueck, D.; Drosten, C.; Eckerle, I.; Edara, V. V.; Ellis, M.; Fouchier, R. A.; Frieman, M.; Godbole, S.; Haagmans, B.; Halfmann, P.; Henry, A. R.; Jones, T. C.; Katzelnick, L.; Kawaoka, Y.; Kimpel, J.; Krammer, F.; Lai, L.; Liu, C.; Lusvarghi, S.; Meyer, B.; Mongkolsapaya, J.; Montefiori, D.; Mykytyn, A. Z.; Netzl, A.; Pollett, S.; Rössler, A.; Screaton, G.; Shen, X.; Sigal, A.; Simon, V.; Subramanian, R.; Supasa, P.; Suthar, M.; Tureli, S.; Wang, W.; We
Show abstract
The antigenic evolution of SARS-CoV-2 requires ongoing monitoring to judge the immune escape of newly arising variants. A surveillance system necessitates an understanding of differences in neutralization titers measured in different assays and using human and animal sera. We compared 18 datasets generated using human, hamster, and mouse sera, and six different neutralization assays. Titer magnitude was lowest in human, intermediate in hamster, and highest in mouse sera. Fold change, immunodominance patterns and antigenic maps were similar among sera. Most assays yielded similar results, except for differences in fold change in cytopathic effect assays. Not enough data was available for conclusively judging mouse sera, but hamster sera were a consistent surrogate for human first-infection sera.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Viral load and timing of infection define neutralization diversity to SARS-CoV-2 infection 96%
- Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 95%
- T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome. 95%
Similar papers in this journal
- Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens 96%
- Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses 96%
- A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy 96%
Similar papers in this journal
- Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants 97%
- Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles 96%
- SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma 95%
Similar papers in this journal
- Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants 96%
- COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins 95%
- Epitope profiling reveals binding signatures of SARS-CoV-2 immune response and cross-reactivity with endemic HCoVs 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.